Page 66 - OR-1-1

doi: 10.1021/acs.chemrev.9b00789 the complexity of the tumour immune microenvironment.
Nat Rev Cancer. 2024;24:523-539.
147. Bredenoord AL, Clevers H, Knoblich JA. Human tissues in
a dish: The research and ethical implications of organoid doi: 10.1038/s41568-024-00706-6
technology. Science. 2017;355:eaaf9414.
150. Yuki K, Cheng N, Nakano M, Kuo CJ. Organoid models of
doi: 10.1126/science.aaf9414 tumor immunology. Trends Immunol. 2020;41:652-664.
148. Gao M, Ding W, Wang Y, et al. Quantitatively evaluating doi: 10.1016/j.it.2020.06.010
interactions between patient-derived organoids and 151. Huang L, Holtzinger A, Jagan I, et al. Ductal pancreatic cancer
autologous immune cells by microfluidic chip. Anal Chem. modeling and drug screening using human pluripotent
2024;96:13061-13069.
stem cell-and patient-derived tumor organoids. Nat Med.
doi: 10.1021/acs.analchem.4c01389 2015;21:1364-1371.
149. Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: Modelling doi: 10.1038/nm.3973

Volume 1 Issue 1 (2025) 19 doi: 10.36922/OR025040007